Expanding the Therapeutic Landscape of Minoxidil for Androgenetic Alopecia: Topical, Oral and Sublingual Formulations

    January 2026 in “ Frontiers in Pharmacology ”
    Flávia Dias, Shin Shen Yong, Holly FitzGerald … Bevin Bhoyrul
    Studysummary This review reports that topical minoxidil remains the primary treatment for androgenetic alopecia, while oral and sublingual forms offer alternative options, each with varying efficacy and side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on public-pages-files-2025.frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 76

    1. Minoxidil Overdose: A Case Report and Review of the Literature Cureus · 2025
    2. Cardiac Tamponade Due To Minoxidil Use: A Case Report And Review Of The Literature European Journal of Case Reports in Internal Medicine · 2025
    3. Continued Year-On-Year Improvement in Hair Density With Systemic Minoxidil in Women With Female Pattern Hair Loss: A Case Series Journal of the American Academy of Dermatology · 2025
    4. Sublingual Minoxidil Increases Fiber Diameter in Male Androgenetic Alopecia: A Proxy for Reversal of Hair Follicle Miniaturization PubMed · 2025
    5. Sublingual Minoxidil 5 mg Versus Oral Minoxidil 5 mg for Male Androgenetic Alopecia: A Double-Blind Randomized Clinical Trial Journal of the European Academy of Dermatology and Venereology · 2024
    6. Applications and Efficacy of Minoxidil in Dermatology Skin Health and Disease · 2024
    7. A Very Bad Hair Day: Minoxidil Ingestion Causing Shock and Heart Failure Cureus · 2024
    8. Prospective Evaluation of Blood Pressure, Heart Rate, and Side Effects in Hypertensive Patients Using Low-Dose Oral Minoxidil for Hair Loss Journal of the American Academy of Dermatology · 2024
    9. Topical Minoxidil Overdose in a Young Man With Androgenetic Alopecia: A Case Report Curēus · 2024
    10. Meta-Analysis of Efficacy of Platelet-Rich Plasma Combined with Minoxidil for Androgenetic Alopecia Aesthetic plastic surgery · 2024
    11. The Impact of Monotherapies for Male Androgenetic Alopecia: A Network Meta-Analysis Study Journal of cosmetic dermatology · 2024
    12. Oral Minoxidil Versus Topical Minoxidil for Male Androgenetic Alopecia JAMA dermatology · 2024
    13. Severe and Refractory Hypotension After Intentional Minoxidil Overdose: A Case Report Toxicology communications · 2023
    14. Clinical Efficacy and Safety of Low-Dose Oral Minoxidil Versus Topical Solution in the Improvement of Androgenetic Alopecia: A Randomized Controlled Trial Journal of Cosmetic Dermatology · 2023
    15. Minoxidil Overdose With Hypotension Effectively Managed With Norepinephrine, Rather Than Dopamine Clinical Toxicology · 2023
    16. Serious Adverse Effects From Compounding Errors With Low-Dose Oral Minoxidil for Alopecia Treatment Actas Dermo-Sifiliográficas · 2022
    17. The Inflammatory Component of Androgenetic Alopecia Journal of The American Academy of Dermatology · 2021
    18. A Randomized Clinical Trial on Therapeutic Effects of 0.25 mg Oral Minoxidil Tablets on Treatment of Female Pattern Hair Loss Dermatologic Therapy · 2021
    19. Sublingual Minoxidil for the Treatment of Male and Female Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase 1B Clinical Trial Journal of The European Academy of Dermatology and Venereology · 2021
    20. Minoxidil: A Comprehensive Review Journal of Dermatological Treatment · 2021
    21. Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients Journal of The American Academy of Dermatology · 2021
    22. Adverse Effects of Low-Dose Oral Minoxidil for Androgenetic Alopecia in 435 Patients Journal of The American Academy of Dermatology · 2020
    23. Safety of Low-Dose Oral Minoxidil Treatment for Hair Loss: A Systematic Review and Pooled Analysis of Individual Patient Data Dermatologic Therapy · 2020
    24. Minoxidil Sulfotransferase Enzyme (SULT1A1) Genetic Variants Predict Response to Oral Minoxidil Treatment for Female Pattern Hair Loss Journal of The European Academy of Dermatology and Venereology · 2020
    25. Treatment of Male and Female Pattern Hair Loss with Sublingual Minoxidil: A Retrospective Case-Series of 64 Patients Journal of The European Academy of Dermatology and Venereology · 2020
    26. How Safe Is Prescribing Oral Minoxidil in Patients Allergic to Topical Minoxidil? Journal of The American Academy of Dermatology · 2020
    27. Efficacy of Non-Surgical Treatments for Androgenetic Alopecia in Men and Women: A Systematic Review with Network Meta-Analyses and an Assessment of Evidence Quality Journal of Dermatological Treatment · 2020
    28. Skin and Hair Abnormalities of Cantu Syndrome: A Congenital Hypertrichosis Due to a Genetic Alteration Mimicking the Pharmacological Effect of Minoxidil Journal of Dermatology · 2020
    29. Minoxidil 1 mg Oral Versus Minoxidil 5% Topical Solution for the Treatment of Female-Pattern Hair Loss: A Randomized Clinical Trial Journal of The American Academy of Dermatology · 2019
    30. Oral Minoxidil Bio-Activation by Hair Follicle Outer Root Sheath Cell Sulfotransferase Enzymes Predicts Clinical Efficacy in Female Pattern Hair Loss Journal of The European Academy of Dermatology and Venereology · 2019
    31. Minoxidil And Its Use In Hair Disorders: A Review Drug Design Development and Therapy · 2019
    32. Effectiveness and Safety of Low-Dose Oral Minoxidil in Male Androgenetic Alopecia Journal of The American Academy of Dermatology · 2019
    33. Female Pattern Hair Loss: A Pilot Study Investigating Combination Therapy with Low-Dose Oral Minoxidil and Spironolactone International Journal of Dermatology · 2017
    34. Androgenetic Alopecia: A Review Endocrine · 2017
    35. Refractory Shock Following Ingestion of Topical Minoxidil Solution Medical journal, Armed Forces India · 2016
    36. Effect of Minoxidil Topical Foam on Frontotemporal and Vertex Androgenetic Alopecia in Men: A 104-Week Open-Label Clinical Trial Journal of The European Academy of Dermatology and Venereology · 2015
    37. Combined Treatment with Oral Finasteride and Topical Minoxidil in Male Androgenetic Alopecia: A Randomized and Comparative Study in Chinese Patients Dermatologic Therapy · 2015
    38. Oxidative Stress-Associated Senescence in Dermal Papilla Cells of Men with Androgenetic Alopecia Journal of Investigative Dermatology · 2015
    39. Sulfotransferase Activity in Plucked Hair Follicles Predicts Response to Topical Minoxidil in the Treatment of Female Androgenetic Alopecia Dermatologic Therapy · 2014
    40. Novel Enzymatic Assay Predicts Minoxidil Response in the Treatment of Androgenetic Alopecia Dermatologic Therapy · 2013
    41. A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study International Journal of Trichology · 2013
    42. Persistent Sexual Side Effects of Finasteride: Could They Be Permanent? The Journal of Sexual Medicine · 2012
    43. Minoxidil Use in Dermatology, Side Effects, and Recent Patents Recent Patents on Inflammation & Allergy Drug Discovery · 2012
    44. A Randomized, Single-Blind Trial of 5% Minoxidil Foam Once Daily Versus 2% Minoxidil Solution Twice Daily in the Treatment of Androgenetic Alopecia in Women Journal of The American Academy of Dermatology · 2011
    45. Beta-Catenin Activity in the Dermal Papilla Regulates Morphogenesis and Regeneration of Hair Developmental Cell · 2010
    46. Treatment Strategies for Alopecia Expert Opinion on Pharmacotherapy · 2009
    47. Minoxidil Topical Foam: A New Kid on the Block International journal of trichology · 2009
    48. Male-Pattern Baldness Susceptibility Locus at 20p11 Nature Genetics · 2008
    49. A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2007
    50. Efficacy And Safety Of A New Clobetasol Propionate 0.05% Foam In Alopecia Areata: A Randomized, Double-Blind Placebo-Controlled Trial Journal of the European Academy of Dermatology and Venereology · 2006
    51. Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia American Journal of Human Genetics · 2005
    52. Minoxidil: An Underused Vasodilator for Resistant or Severe Hypertension Journal of Clinical Hypertension · 2004
    53. A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2004
    54. Effect of Minoxidil on Proliferation and Apoptosis in Dermal Papilla Cells of Human Hair Follicle Journal of Dermatological Science · 2004
    55. Minoxidil: Mechanisms of Action on Hair Growth British Journal of Dermatology · 2004
    56. Hypertrichosis in Females Applying Minoxidil Topical Solution and in Normal Controls Journal of The European Academy of Dermatology and Venereology · 2003
    57. Androgens and Alopecia Molecular and Cellular Endocrinology · 2002
    58. A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2002
    59. Prostaglandin-Induced Hair Growth Survey of Ophthalmology · 2002
    60. Molecular Mechanisms of Androgenetic Alopecia Experimental Gerontology · 2002
    61. Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2001
    62. Control of Hair Growth and Follicle Size by VEGF-Mediated Angiogenesis Journal of Clinical Investigation · 2001
    63. Hair Density, Hair Diameter, and the Prevalence of Female Pattern Hair Loss British Journal of Dermatology · 2001
    64. Differences in Hair Follicle Dermal Papilla Volume Are Due to Extracellular Matrix Volume and Cell Number: Implications for the Control of Hair Follicle Size and Androgen Responses Journal of Investigative Dermatology · 1999
    65. The Induction by Topical Minoxidil of Increased Fenestration in the Perifollicular Capillary Wall British Journal of Dermatology · 1999
    66. Overdose of Rogaine Extra Strength for Men Topical Minoxidil Preparation Journal of Toxicology Clinical Toxicology · 1999
    67. Minoxidil Upregulates the Expression of Vascular Endothelial Growth Factor in Human Hair Dermal Papilla Cells British Journal of Dermatology · 1998
    68. Activation of Cytoprotective Prostaglandin Synthase-1 by Minoxidil as a Possible Explanation for Its Hair Growth-Stimulating Effect Journal of Investigative Dermatology · 1997
    69. The Effect of Minoxidil Analogues and Metabolites on the Contraction of Collagen Lattices by Human Skin Fibroblasts British Journal of Plastic Surgery · 1995
    70. Relative Influence of Ethanol and Propylene Glycol Cosolvents on Deposition of Minoxidil into the Skin Journal of Pharmaceutical Sciences · 1994
    71. Diagnostic and Predictive Value of Horizontal Sections of Scalp Biopsy Specimens in Male Pattern Androgenetic Alopecia Journal of The American Academy of Dermatology · 1993
    72. Minoxidil Overdose: Severe Hypotension and Tachycardia After Ingestion Chest · 1993
    73. The Psychological Effects of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 1992
    74. Mechanism of Action of Minoxidil Sulfate-Induced Vasodilation: A Role for Increased Potassium Permeability PubMed · 1988
    75. Pharmacology and Pharmacokinetics of Minoxidil Journal of Cardiovascular Pharmacology · 1980
    76. Minoxidil Southern Medical Journal · 1980